Table 2 Absolute cells count in peripheral blood at basal, 2 m and 6 m of anti-TB therapy
Absolute cells count | DS-TB (N = 13) | DR-TB (N = 7) |
|---|---|---|
Basal | ||
Leukocytes, media (SD), (RV 4–10 × 103 cells/mm3) | 11.5 (3.40) | 9.98 (3.03) |
Neutrophils, media (SD), (RV 2–7.5 × 103 cells/mm3) | 8.95 (3.5) | 7.67 (2.87) |
Lymphocytes, media (SD), (RV 1–4 × 103 cells/mm3) | 1.72 (0.78) | 1.6 (0.33) |
Monocytes, media (SD), (RV 0.2–1 × 103 cells/mm3) | 0.87 (0.48) | 0.66 (0.24) |
2 months of anti-TB therapy | ||
Leukocytes, media (SD), (RV 4–10 × 103 cells/mm3) | 6.75 (2.39) | 6.8 (1.85) |
Neutrophils, media (SD), (RV 2–7.5 × 103 cells/mm3) | 4.0 (2.36) | 4.47 (1.41) |
Lymphocytes, media (SD), (RV 1–4 × 103 cells/mm3) | 1.80 (0.86) | 1.45 (0.57) |
Monocytes, media (SD), (RV 0.2–1 × 103 cells/mm3) | 0.51 (0.31) | 0.72 (0.19) |
6 months of anti-TB therapy | ||
Leukocytes, media (SD), (RV 4–10 × 103 cells/mm3) | 6.8 (1.86) | 6.35 (1.50) |
Neutrophils, media (SD), (RV 2–7.5 × 103 cells/mm3) | 4.03 (1.53) | 4.07 (1.16) |
Lymphocytes, media (SD), (RV 1–4 × 103 cells/mm3) | 2.01 (0.69) | 1.41 (0.41) |
Monocytes, media (SD), (RV 0.2–1 × 103 cells/mm3) | 0.56 (0.24) | 0.62 (0.13) |